Professor of Pediatrics, University Ariz College of Medicine
Pediatric Pulmonology
Dr. Wayne J. Morgan, MD
|
|
Give Review
Wayne Morgan works in the field of Pediatric Pulmonology. He received 2 awards: "America's Top Doctors" and "Top Doctors:Arizona State". Dr. Wayne J. Morgan is a published doctor as well. He has 93 publications published. The latest was: Modified STOP-Bang Tool for Stratifying Obstructive Sleep Apnea Risk in Adolescent Children.
Publications
- Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Cl...
- Effects of exercise intensity compared to albuterol in individuals with Cystic fibrosis.
- Pneumonia in Childhood and Impaired Lung Function in Adults: A Longitudinal Study.
- Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children With Mild Persistent Asthma.
- Seasonal risk factors for asthma exacerbations among inner-city children.
- Pulmonary function outcomes for assessing Cystic fibrosis care.
- Antibiotic treatment of signs and symptoms of pulmonary exacerbations: A comparison by care site.
- Serology as a diagnostic tool for predicting initial Pseudomonas aeruginosa acquisition in children with Cystic fibrosis.
- Liver Involvement in the Hispanic Cystic Fibrosis Population of North America.
- Risk of Current Asthma Among Adult Smokers with Respiratory Syncytial Virus Illnesses in Early Life.
- Pseudomonas aeruginosa in vitro Phenotypes Distinguish Cystic Fibrosis Infection Stages and Outcomes.
- Predictors of Specific Airway Resistance during Childhood.
- Eczema and race as combined determinants for differential response to step-up asthma therapy.
- The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing.
- Clinical outcomes after initial Pseudomonas acquisition in Cystic fibrosis.
- Early childhood wheezing is associated with lower lung function in Cystic fibrosis.
- Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in Cystic fibrosis.
- Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
- Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in Cystic fibrosis.
- Pulmonary exacerbations in Cystic fibrosis: young children with characteristic signs and symptoms.
- Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in Cystic fibrosis.
- Combined effects of parental and active smoking on early lung function deficits: a prospective study from birth to age 26 years.
- Does COPD begin in childhood?
- Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents.
- Probability of Treatment Following Acute Decline in Lung Function in Children with Cystic Fibrosis is Related to Baseline Pulmonary Function.
- Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents.
- Changing thresholds and incidence of antibiotic treatment of Cystic fibrosis pulmonary exacerbations, 1995-2005.
- Lymphoscintigraphy in plastic Bronchitis, A pediatric case report.
- Genetic Variation of SCNN1A Influences Lung Diffusing Capacity in Cystic Fibrosis.
- Long-term outcomes of early-onset wheeze and asthma.
- Successful treatment of plastic Bronchitis with low fat diet and subsequent thoracic duct ligation in child with fontan physiology.
- Development and validation of the Composite Asthma Severity Index-an outcome measure for use in children and adolescents.
- Influence of genetic variation of the β2-adrenergic receptor on lung diffusion in patients with Cystic fibrosis.
- Relation of early childhood growth and wheezing phenotypes to adult lung function.
- Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
- Pulmonary outcome prediction (POP) tools for Cystic fibrosis patients.
- Differential effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children.
- Asthma control, adiposity, and adipokines among inner-city adolescents.
- Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma.
- Lower airway obstruction is associated with increased morbidity in children with sickle cell disease.
- Effect of breastfeeding on lung function in childhood and modulation by maternal asthma and atopy.
- The outcomes of sickle cell disease in adulthood are clear, but the origins and progression of sickle cell anemia-induced problems in the heart and lung in childhood a...
- A randomized clinical trial of clinician feedback to improve quality of care for inner-city children with asthma.
- Long-term inhaled corticosteroids in preschool children at high risk for asthma.
- Behavior problems associated with Sleep disordered breathing in school-aged children--the Tucson children's assessment of Sleep apnea study.
- Impact of pregnancy on women with Cystic fibrosis.
- Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence.
- Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma.
- Relation of beta2-adrenoceptor polymorphisms at codons 16 and 27 to persistence of asthma symptoms after the onset of puberty.
- Clinical screening of school children for polysomnography to detect Sleep-disordered breathing--the Tucson Children's Assessment of Sleep Apnea study (TuCASA).
- Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity.
- Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
- Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma.
- Airborne fungi in the homes of children with asthma in low-income urban communities: The Inner-City Asthma Study.
- Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty.
- Clinical outcomes associated with Sleep-disordered breathing in Caucasian and Hispanic children--the Tucson Children's Assessment of Sleep Apnea study (TuCASA).
- Tucson Children's Respiratory Study: 1980 to present.
- Modified STOP-Bang Tool for Stratifying Obstructive Sleep Apnea Risk in Adolescent Children.
- Exhaled breath condensate detects baseline reductions in chloride and increases in response to albuterol in Cystic fibrosis patients.
- Symptoms related to Sleep-disordered breathing in white and Hispanic children: the Tucson Children''s Assessment of Sleep Apnea Study.
- Growth and nutritional indexes in early life predict pulmonary function in Cystic fibrosis.
- Learning in children and Sleep disordered breathing: findings of the Tucson Children''s Assessment of Sleep Apnea (tuCASA) prospective cohort study.
- Sleep architecture in normal Caucasian and Hispanic children aged 6-11 years recorded during unattended home polysomnography: experience from the Tucson Children''s As...
- Results of a home-based environmental intervention among urban children with asthma.
- The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network.
- Ventilatory drive and the Apnea-hypopnea index in six-to-twelve year old children.
- Parasomnias and Sleep disordered breathing in Caucasian and Hispanic children - the Tucson children''s assessment of Sleep apnea study.
- Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
- Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with Cystic fibrosis.
- Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from Cystic fibrosis patients is associated with lower lung function.
- Infant care patterns at epidemiologic study of Cystic fibrosis sites that achieve superior childhood lung function.
- Comparison between reported and recorded total Sleep time and Sleep latency in 6- to 11-year-old children: the Tucson Children''s Assessment of Sleep Apnea Study (TuCA...
- Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
- Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
- Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study.
- Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.
- Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study.
- Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with Cystic fibrosis.
- Trends in the clinical characteristics of the U.S. Cystic fibrosis patient population from 1995 to 2005.
- Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.
- Relationship between infant weight gain and later asthma.
- Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma.
- Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
- Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.
- Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with Cystic fi...
- Trends in the use of routine therapies in Cystic fibrosis: 1995-2005.
- Year-to-year changes in lung function in individuals with Cystic fibrosis.
- Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in Cystic fibrosis.
- Lung function decline from adolescence to young adulthood in Cystic fibrosis.
- Daily or intermittent budesonide in preschool children with recurrent wheezing.
- Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with Cystic fibrosis.
- Longitudinal differences in Sleep duration in Hispanic and Caucasian children.
Schools
McGill University Faculty Of Medicine
Montreal Chldns Hospital
University Ariz
Procedures Preformed
- Bronchoscopy
Conditions Treated
- Bronchitis
- Cystic Fibrosis
- Pneumonia
- Sleep Apnea
- View All
Doctors Specialties
- Pediatric Pulmonology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Arizona State
Education
-
University of Arizona -
McGill University Faculty of Medicine
Hospital
-
TMC Healthcare
Drug Facts
| NPI NUMBER | 1649295569 | |
| NPPES Provider LastName | MORGAN | |
| NPPES Provider FirstName | WAYNE | |
| NPPES Provider ZIPCode | 85711 | |
| NPPES Provider State | AZ | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 34.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649295569 |
| Last Name Of The Provider | MORGAN |
| First Name Of The Provider | WAYNE |
| View All |
Similar Doctors
|
|
Dr. Linda L. Riordan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roni Grad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Brown, MD |
|
|
Dr. Diane Neddenriep, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cori L. Daines, MD |
|
|
Dr. Annette R. Lopez, MD |
|
|
Dr. Nadine Mokhallati, MD |